Stereotaxis, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Stereotaxis, Inc. on November 15, 2010, covering events occurring on November 10 and November 11, 2010. The filing details a material definitive agreement regarding a public equity offering and an extension of a private financing commitment.
Key Financial Metrics and Transactions
- Public Equity Offering: The Company executed an underwriting agreement to sell 4,000,000 shares of common stock at $3.65 per share, with an option for underwriters to acquire an additional 600,000 shares.
- Expected Proceeds: Net proceeds from the public offering are estimated at approximately $13.4 million after underwriting discounts and expenses.
- Private Financing Extension: Lenders (Alafi Capital Company LLC and affiliates of Sanderling Venture Partners) agreed to extend a $10 million financing commitment. This can be provided as direct loans or guarantees for the Company's working capital facility with Silicon Valley Bank.
- Warrant Issuance: In exchange for the financing extension, the Company agreed to issue warrants to purchase 800,000 shares of common stock at an exercise price of $4.015 per share.
Material Changes and Agreements
The primary material change is the execution of the Underwriting Agreement for the public offering and the amendment to the Note and Warrant Purchase Agreement with existing lenders. The lenders' commitment, originally effective February 7, 2008, now expires on the earlier of March 31, 2012, or the date the Company secures at least $30 million in third-party, non-bank financing.
Outlook, Risks, and Contingencies
The filing indicates the Company is actively raising capital to support operations, evidenced by the public offering and the extension of the private credit facility. The financing extension is contingent on the Company not receiving $30 million in other third-party financing before March 31, 2012. The underwriting agreement includes customary indemnification provisions where the Company agrees to indemnify underwriters against certain liabilities.
Key Facts for Investor Verification
- Verify the final closing date and actual net proceeds of the 4,000,000 share public offering.
- Confirm whether the underwriters exercised the option to purchase the additional 600,000 shares.
- Monitor the status of the $10 million lender commitment and whether it is utilized as direct loans or bank guarantees.
- Track the Company's progress toward securing the $30 million in third-party non-bank financing, which would terminate the current lender commitment early.
- Review the dilution impact of the 800,000 warrants issued to lenders at the $4.015 exercise price.